Sensei Biotherapeutics, Inc. (SNSE) Financials
Stock symbol SNSE is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker SNSE was renamed to
FTH
effective 2026-06-16.
SNSE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 205.4 million | 14.2 million |
| Dec. 31, 2025 | 22.9 million | 4.3 million |
| Sept. 30, 2025 | 27.6 million | 4.6 million |
| June 30, 2025 | 31.8 million | 4.5 million |
SNSE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -10.7 million | 12.9 million |
| Dec. 31, 2025 | -3.9 million | 295000 |
| Sept. 30, 2025 | -3.6 million | 254000 |
| June 30, 2025 | -5.9 million | 264000 |
SNSE Net Income
No data available :(
SNSE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 202.8 million | - | - |
| Dec. 31, 2025 | 21.2 million | 59000 | 1.5 million |
| Sept. 30, 2025 | 25.0 million | - | 146000 |
| June 30, 2025 | 28.6 million | - | 596000 |
SNSE Shares Outstanding
SNSE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 6000 | 18.0 million | 19.7 million | - |
| Dec. 31, 2025 | - | 2.2 million | 2.8 million | - |
| Sept. 30, 2025 | - | 2.5 million | 2.3 million | - |
| June 30, 2025 | 16000 | 2.5 million | 2.7 million | - |
SNSE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 133.0 million |
| Dec. 31, 2025 | - | 4.8 million |
| Sept. 30, 2025 | -4.9 million | -4.9 million |
| June 30, 2025 | - | 37000 |
SNSE
Price: $13.85
52 week price:
Earnings Per Share: -16.72 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18884
Market Capitalization: 19.7 million